Matteo Ruggeri

2.5k total citations
105 papers, 1.3k citations indexed

About

Matteo Ruggeri is a scholar working on Economics and Econometrics, Epidemiology and Hepatology. According to data from OpenAlex, Matteo Ruggeri has authored 105 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Economics and Econometrics, 19 papers in Epidemiology and 16 papers in Hepatology. Recurrent topics in Matteo Ruggeri's work include Health Systems, Economic Evaluations, Quality of Life (24 papers), Hepatitis C virus research (14 papers) and Pharmaceutical Economics and Policy (11 papers). Matteo Ruggeri is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (24 papers), Hepatitis C virus research (14 papers) and Pharmaceutical Economics and Policy (11 papers). Matteo Ruggeri collaborates with scholars based in Italy, United Kingdom and United States. Matteo Ruggeri's co-authors include Silvia Coretti, Paul McNamee, Americo Cicchetti, Carlo Drago, Marco Marchetti, Andrea Gatto, Marjon van der Pol, Flaminia Coluzzi, Antonio Gasbarrini and Gennaro De Pascale and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Matteo Ruggeri

99 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matteo Ruggeri Italy 18 297 237 159 152 127 105 1.3k
Ahmed Al‐Jedai Saudi Arabia 20 157 0.5× 120 0.5× 60 0.4× 93 0.6× 37 0.3× 106 950
Miquel Serra‐Burriel Spain 20 255 0.9× 70 0.3× 383 2.4× 136 0.9× 59 0.5× 58 1.3k
Rajiv Mallick United States 19 167 0.6× 177 0.7× 138 0.9× 22 0.1× 131 1.0× 70 1.3k
Deven Juneja India 19 509 1.7× 62 0.3× 320 2.0× 49 0.3× 60 0.5× 87 1.8k
Shou‐Chuan Shih Taiwan 23 425 1.4× 54 0.2× 598 3.8× 84 0.6× 52 0.4× 125 2.0k
Kelly L. Moore United States 23 1.1k 3.7× 135 0.6× 105 0.7× 322 2.1× 33 0.3× 45 2.2k
Rebecca W. Stubbs United States 10 209 0.7× 198 0.8× 81 0.5× 27 0.2× 58 0.5× 14 1.3k
Aliza K. Fink United States 24 368 1.2× 370 1.6× 265 1.7× 20 0.1× 50 0.4× 65 3.2k
M Fasihul Alam United Kingdom 18 406 1.4× 75 0.3× 96 0.6× 34 0.2× 39 0.3× 55 1.2k
Fernando Antoñanzas Spain 23 404 1.4× 768 3.2× 211 1.3× 96 0.6× 16 0.1× 140 2.3k

Countries citing papers authored by Matteo Ruggeri

Since Specialization
Citations

This map shows the geographic impact of Matteo Ruggeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Ruggeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Ruggeri more than expected).

Fields of papers citing papers by Matteo Ruggeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Ruggeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Ruggeri. The network helps show where Matteo Ruggeri may publish in the future.

Co-authorship network of co-authors of Matteo Ruggeri

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Ruggeri. A scholar is included among the top collaborators of Matteo Ruggeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Ruggeri. Matteo Ruggeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietrantonio, Filomena, Francesco Rosiello, Matteo Ruggeri, et al.. (2024). Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study. SHILAP Revista de lepidopterología. 18(2).
2.
Rosiello, Francesco, Antonio Vinci, Matteo Vitali, et al.. (2024). Is Rome ready to react to chemical, biological, radiological, nuclear, and explosive attacks? A tabletop simulation. SHILAP Revista de lepidopterología. 18(2). 1 indexed citations
3.
Pietrantonio, Filomena, Antonio Vinci, Massimo Maurici, et al.. (2023). Intra- and Extra-Hospitalization Monitoring of Vital Signs—Two Sides of the Same Coin: Perspectives from LIMS and Greenline-HT Study Operators. Sensors. 23(12). 5408–5408. 8 indexed citations
4.
Pietrantonio, Filomena, Antonio Vinci, Tiziana Ciarambino, et al.. (2023). Polypharmacy Management in a Gender Perspective: At the Heart of the Problem: Analysis of Major Cardiac Diseases, SARS-CoV-2 Affection and Gender Distribution in a Cohort of Patients in Internal Medicine Ward. International Journal of Environmental Research and Public Health. 20(9). 5711–5711. 4 indexed citations
5.
Ruggeri, Matteo, et al.. (2021). Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain. Clinical Drug Investigation. 41(10). 875–883. 4 indexed citations
6.
Ruggeri, Matteo, Stefania Boccia, Domenica Lorusso, et al.. (2020). A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer. SHILAP Revista de lepidopterología. 7(1). 1–8. 1 indexed citations
7.
Mennini, Francesco Saverio, Andrea Marcellusi, Alessandro Giunta, et al.. (2019). The economic impact of biosimilars in Italy: a scenario analysis. SHILAP Revista de lepidopterología. 6(1). 2 indexed citations
8.
Ruggeri, Matteo, et al.. (2019). Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitis. SHILAP Revista de lepidopterología. 6(1). 1 indexed citations
9.
Ruggeri, Matteo, et al.. (2016). Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian Population. Value in Health. 19(7). A415–A415. 1 indexed citations
10.
Cicchetti, Americo, et al.. (2016). Cost-Effectiveness of A Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus A No Test Strategy. Value in Health. 19(7). A696–A696. 1 indexed citations
11.
Orlando, Valentina, et al.. (2015). Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs. ClinicoEconomics and Outcomes Research. 7. 575–575. 17 indexed citations
12.
Ruggeri, Matteo & Silvia Coretti. (2015). Do Probability and Certainty Equivalent Techniques Lead to Inconsistent Results? Evidence from Gambles Involving Life-Years and Quality of Life. Value in Health. 18(4). 413–424. 2 indexed citations
13.
Ruggeri, Matteo, et al.. (2015). Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature. Risk Management and Healthcare Policy. 8. 45–45. 17 indexed citations
14.
Ruggeri, Matteo, Americo Cicchetti, Silvia Coretti, & Antonio Gasbarrini. (2014). Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia.. 2014(3). 75–84. 1 indexed citations
15.
Ruggeri, Matteo, et al.. (2014). Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis. Value in Health. 17(7). A393–A393. 1 indexed citations
16.
Coluzzi, Flaminia & Matteo Ruggeri. (2014). Valutazione clinica ed economica di nuovi analgesici per la gestione del dolore cronico. Recenti Progressi in Medicina. 105(11). 415–9. 1 indexed citations
17.
Coretti, Silvia, Matteo Ruggeri, & Paul McNamee. (2014). From The Minimum Clinically Important Difference To The Minimum Cost Effective Difference For Eq-5d In Patients With Chronic Widespread Pain. Value in Health. 17(3). A50–A51. 3 indexed citations
18.
Ruggeri, Matteo, Silvia Coretti, Antonio Gasbarrini, & Americo Cicchetti. (2013). Economic Assessment of an Anti-HCV Screening Program in Italy. Value in Health. 16(6). 965–972. 28 indexed citations
19.
Cicchetti, Americo & Matteo Ruggeri. (2009). Valutazione economica di ranibizumab vs pegaptanib o vs terapiafotodinamica con verteporfina. Italian Journal of Public Health. 6. 1 indexed citations
20.
Valentini, Gabriele, et al.. (2003). Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease. Techniques in Coloproctology. 7(3). 173–177. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Al‐Jedai Breakdown of academic impact, for papers by Miquel Serra‐Burriel Breakdown of academic impact, for papers by Rajiv Mallick Breakdown of academic impact, for papers by Deven Juneja Breakdown of academic impact, for papers by Shou‐Chuan Shih Breakdown of academic impact, for papers by Kelly L. Moore Breakdown of academic impact, for papers by Rebecca W. Stubbs Breakdown of academic impact, for papers by Aliza K. Fink Breakdown of academic impact, for papers by M Fasihul Alam Breakdown of academic impact, for papers by Fernando Antoñanzas
Rankless by CCL
2026